rs17171525

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_017415.3(KLHL3):​c.1611G>T​(p.Gly537Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0414 in 1,614,148 control chromosomes in the GnomAD database, including 2,071 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 221 hom., cov: 32)
Exomes 𝑓: 0.042 ( 1850 hom. )

Consequence

KLHL3
NM_017415.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.184

Publications

6 publications found
Variant links:
Genes affected
KLHL3 (HGNC:6354): (kelch like family member 3) This gene is ubiquitously expressed and encodes a full-length protein which has an N-terminal BTB domain followed by a BACK domain and six kelch-like repeats in the C-terminus. These kelch-like repeats promote substrate ubiquitination of bound proteins via interaction of the BTB domain with the CUL3 (cullin 3) component of a cullin-RING E3 ubiquitin ligase (CRL) complex. Muatations in this gene cause pseudohypoaldosteronism type IID (PHA2D); a rare Mendelian syndrome featuring hypertension, hyperkalaemia and metabolic acidosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012]
KLHL3 Gene-Disease associations (from GenCC):
  • pseudohypoaldosteronism type 2D
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 5-137625877-C-A is Benign according to our data. Variant chr5-137625877-C-A is described in ClinVar as Benign. ClinVar VariationId is 260808.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.184 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL3NM_017415.3 linkc.1611G>T p.Gly537Gly synonymous_variant Exon 14 of 15 ENST00000309755.9 NP_059111.2
KLHL3NM_001257194.1 linkc.1515G>T p.Gly505Gly synonymous_variant Exon 14 of 15 NP_001244123.1
KLHL3NM_001257195.2 linkc.1365G>T p.Gly455Gly synonymous_variant Exon 12 of 13 NP_001244124.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL3ENST00000309755.9 linkc.1611G>T p.Gly537Gly synonymous_variant Exon 14 of 15 1 NM_017415.3 ENSP00000312397.4

Frequencies

GnomAD3 genomes
AF:
0.0363
AC:
5524
AN:
152186
Hom.:
218
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.0213
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0155
Gnomad FIN
AF:
0.0198
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0422
Gnomad OTH
AF:
0.0435
GnomAD2 exomes
AF:
0.0484
AC:
12160
AN:
251402
AF XY:
0.0429
show subpopulations
Gnomad AFR exome
AF:
0.00966
Gnomad AMR exome
AF:
0.178
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.000652
Gnomad FIN exome
AF:
0.0207
Gnomad NFE exome
AF:
0.0384
Gnomad OTH exome
AF:
0.0386
GnomAD4 exome
AF:
0.0420
AC:
61351
AN:
1461844
Hom.:
1850
Cov.:
32
AF XY:
0.0403
AC XY:
29328
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.00789
AC:
264
AN:
33480
American (AMR)
AF:
0.171
AC:
7629
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0223
AC:
583
AN:
26136
East Asian (EAS)
AF:
0.000378
AC:
15
AN:
39700
South Asian (SAS)
AF:
0.0184
AC:
1587
AN:
86258
European-Finnish (FIN)
AF:
0.0233
AC:
1246
AN:
53416
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.0430
AC:
47859
AN:
1111966
Other (OTH)
AF:
0.0353
AC:
2130
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2973
5946
8920
11893
14866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1894
3788
5682
7576
9470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0363
AC:
5533
AN:
152304
Hom.:
221
Cov.:
32
AF XY:
0.0364
AC XY:
2712
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0113
AC:
470
AN:
41554
American (AMR)
AF:
0.114
AC:
1739
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
74
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0157
AC:
76
AN:
4828
European-Finnish (FIN)
AF:
0.0198
AC:
210
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0422
AC:
2869
AN:
68026
Other (OTH)
AF:
0.0425
AC:
90
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
270
540
810
1080
1350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0389
Hom.:
500
Bravo
AF:
0.0430
Asia WGS
AF:
0.0140
AC:
47
AN:
3478
EpiCase
AF:
0.0360
EpiControl
AF:
0.0332

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant pseudohypoaldosteronism type 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2D Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
7.5
DANN
Benign
0.67
PhyloP100
0.18
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17171525; hg19: chr5-136961566; COSMIC: COSV59059161; API